ECRI Announces New Insights Meant to Show Which Products Hit Hard by Tariffs

ECRI has announced that it has “launched new data insights to provide transparency and decision-support for eligible clients navigating the impacts of tariffs.”

The announcement comes in the wake of the U.S. imposing “steep tariffs on medical imports from key manufacturing countries.” The new ECRI Supply Chain Navigator will equip “healthcare leaders to make strategic purchasing decisions to achieve continuity of care in an uncertain market.”

Many of the 4,000 health system supply chain teams that use ECRI’s datasets reported that “they’re concerned about how tariffs will impact pricing and availability of critical personal protective equipment (PPE) from China.” The datasets will help “pinpoint where clients’ current products are manufactured and isolate those impacted by tariffs to identify safe alternatives that are functionally equivalent.” These new insights will help to provide a “curated view of country of origin” for products, “customized to certain origin sources and product categories with an emphasis on PPE.”

Alison Maguire, vice president of sales, Americas, for ECRI, said that ECRI’s partners will be able to see “their level of risk and exposure in key product categories based on the tariffs.” They will also “flag supplies that have been identified as hazardous or subject to a recall or lengthy backorders.”